Advertisement

Emerging Novel Pharmacological Non-opioid Therapies in Headache Management: a Comprehensive Review

  • Alan David Kaye
  • Mark W. Motejunas
  • Elyse M. CornettEmail author
  • Ken P. Ehrhardt
  • Matthew B. Novitch
  • Joshua Class
  • Harish Siddaiah
  • Brendon M. Hart
  • Richard D. Urman
Other Pain (A Kaye and N Vadivelu, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Other Pain

Abstract

Purpose of Review

Chronic headache is a significant worldwide problem despite advances in treatment options. Chronic headaches can have significant a detrimental impact on the activities of daily living.

Recent Findings

Patients who do not obtain relief from chronic head and neck pain from conservative treatments are commonly being managed with interventional treatments. These interventional treatment options include botulinum toxin A, injections, local occipital nerve anesthetic and corticosteroid infiltration, occipital nerve subcutaneous stimulation and occipital nerve pulsed radiofrequency (PRF), sphenopalatine ganglion block, and radiofrequency techniques.

Summary

Recently, evidence has emerged to support non-opioid-based drug and interventional approaches. Overall, more research is necessary to clarify the safety and efficacy of interventional treatments and to better understand the pathogenesis of chronic headache pain.

Keywords

Non-opioid Headache Botox Multimodal analgesia 

Notes

Compliance with Ethical Standards

Conflict of Interest

All authors declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

  1. 1.
    Viswanath O, Rasekhi R, Suthar R, Jones MR, Peck J, Kaye AD. Novel interventional nonopioid therapies in headache management. Curr Pain Headache Rep. 2018;22:29.CrossRefGoogle Scholar
  2. 2.
    Mitra S, Carlyle D, Kodumudi G, Kodumudi V, Vadivelu N. New advances in acute postoperative pain management. Curr Pain Headache Rep. 2018;22:35.CrossRefGoogle Scholar
  3. 3.
    Iljazi A, Ayata C, Ashina M, Hougaard A. The role of endothelin in the pathophysiology of migraine—a systematic review. Curr Pain Headache Rep. 2018;22:27.CrossRefGoogle Scholar
  4. 4.
    Dodick DW. A phase-by-phase review of migraine pathophysiology. Headache. 2018;58:4–16.CrossRefGoogle Scholar
  5. 5.
    Burish M. Cluster Headache and other trigeminal autonomic cephalalgias. Contin Lifelong Learn Neurol. 2018;24:1137–56.CrossRefGoogle Scholar
  6. 6.
    Arkink EB, Schmitz N, Schoonman GG, Van Vliet JA, Haan J, Van Buchem MA, et al. The anterior hypothalamus in cluster headache. Cephalalgia. 2017;37:1039–50.CrossRefGoogle Scholar
  7. 7.
    Friedman DI. Headaches due to low and high intracranial pressure. Contin Lifelong Learn Neurol. 2018;24:1066–91.CrossRefGoogle Scholar
  8. 8.
    Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis [Internet] JKL International LLC; 2018 [cited 2019 May 14];9:143–150. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29392089.CrossRefGoogle Scholar
  9. 9.
    Lipton RB, Diener H-C, Robbins MS, Garas SY, Patel K. Caffeine in the management of patients with headache. J Headache Pain [Internet]. BioMed Central; 2017 [cited 2019 May 14];18:107. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29067618.
  10. 10.
    Antonaci F, Ghiotto N, Wu S, Pucci E, Costa A. Recent advances in migraine therapy. Springerplus [Internet]. Springer; 2016 [cited 2019 may 14];5:637. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27330903.
  11. 11.
    Ferrari A, Tiraferri I, Neri L, Sternieri E. Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. J Headache Pain [Internet]. BioMed Central; 2011 [cited 2019 may 14];12:5–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20878535.CrossRefGoogle Scholar
  12. 12.
    NICE guideline - The Migraine Trust [Internet]. [cited 2019 May 14]. Available from: https://www.migrainetrust.org/living-with-migraine/treatments/evidence-based-guidance/nice-guideline/.
  13. 13.
    Tepper SJ. Opioids should not be used in migraine. Headache J Head Face Pain [Internet]. 2012 [cited 2018 Nov 5];52:30–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22540203.
  14. 14.
    Weatherall MW. The diagnosis and treatment of chronic migraine. Ther Adv Chronic Dis [Internet]. 2015 [cited 2018 Nov 5];6:115–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25954496.
  15. 15.
    Jackson JL, Mancuso JM, Nickoloff S, Bernstein R, Kay C. Tricyclic and tetracyclic antidepressants for the prevention of frequent episodic or chronic tension-type headache in adults: a systematic review and meta-analysis. J Gen Intern Med [Internet]. 2017 [cited 2018 Nov 5];32:1351–1358. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28721535.CrossRefGoogle Scholar
  16. 16.
    Leone M, D’Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology [Internet]. 2000 [cited 2018 Nov 5];54:1382–1385. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10746617.CrossRefGoogle Scholar
  17. 17.
    Law S, Derry S, Moore RA. Triptans for acute cluster headache. Cochrane Database Syst Rev [Internet]. 2013 [cited 2018 Nov 5];CD008042. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24353996.
  18. 18.
    Peterson GN, Domino KB, Caplan RA, Posner KL, Lee LA, Cheney FW. Management of the difficult airway: a closed claims analysis. Anesthesiology. 2005;103:33–9.CrossRefGoogle Scholar
  19. 19.
    Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia [Internet]. 2013 [cited 2018 Nov 5];33:629–808. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23771276.
  20. 20.
    Aleksenko D, Sánchez-Manso JC. Headache, Medication Overuse [Internet]. StatPearls. StatPearls Publishing; 2018 [cited 2018 Nov 5]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29262094.
  21. 21.
    Escher CM, Paracka L, Dressler D, Kollewe K. Botulinum toxin in the management of chronic migraine: clinical evidence and experience. Ther Adv Neurol Disord [Internet]. SAGE Publications; 2017 [cited 2019 may 14];10:127–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28382110.
  22. 22.
    Kingston WS, Dodick DW. Treatment of cluster headache. Ann Indian Acad Neurol [Internet]. Wolters Kluwer -- Medknow Publications; 2018 [cited 2019 May 14];21:S9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909137/.CrossRefGoogle Scholar
  23. 23.
    Tao H, Wang T, Dong X, Guo Q, Xu H, Wan Q. Effectiveness of transcutaneous electrical nerve stimulation for the treatment of migraine: a meta-analysis of randomized controlled trials. J Headache Pain [Internet]. BioMed Central; 2018 [cited 2019 may 14];19:42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29845369.
  24. 24.
    Wei DY, Jensen RH. Therapeutic approaches for the management of trigeminal autonomic cephalalgias. Neurotherapeutics [Internet]. Springer; 2018 [cited 2019 may 14];15:346–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29516437.
  25. 25.
    Choi HJ, Oh IH, Choi SK, Lim YJ. Clinical outcomes of pulsed radiofrequency neuromodulation for the treatment of occipital neuralgia. J Korean Neurosurg Soc [Internet]. 2012 May [cited 2019 Jun 3];51(5):281–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22792425.CrossRefGoogle Scholar
  26. 26.
    MANOLITSIS N, Elahi F, Walling I, Panse D, Gee L, Maietta T, et al. Spinal cord stimulation, MILD procedure, and regenerative medicine, novel interventional nonopioid therapies in chronic pain. Pain. Curr Pain Headache Rep. 2018;17:489–97.Google Scholar
  27. 27.
    Elahi F, Ho KWD. Successful management of refractory headache and facial pain due to cavernous sinus meningioma with sphenopalatine ganglion radiofrequency. Case Rep Neurol Med Hindawi Publishing Corporation. 2014;2014:923516.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Cohen SP, Lee Peterlin B, Fulton L, Neely ET, Kurihara C, Gupta A, et al. Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness. Pain. 2015;156:2585–94.CrossRefGoogle Scholar
  29. 29.
    Fang L, Jingjing L, Ying S, Lan M, Tao W, Nan J. Computerized tomography-guided sphenopalatine ganglion pulsed radiofrequency treatment in 16 patients with refractory cluster headaches: twelve- to 30-month follow-up evaluations. Cephalalgia. 2016;36:106–12.CrossRefGoogle Scholar
  30. 30.
    Wilkinson I, Erdek MA. Occipital nerve pulsed radiofrequency treatment : a multi-center study evaluating predictors of outcome; 2012. p. 489–97.Google Scholar
  31. 31.
    Hagiwara S, Iwasaka H, Takeshima N, Noguchi T. Mechanisms of analgesic action of pulsed radiofrequency on adjuvant-induced pain in the rat: roles of descending adrenergic and serotonergic systems. Eur J Pain. 2009;13:249–52.CrossRefGoogle Scholar
  32. 32.
    Kacperski J, Bazarsky A. New Developments in the Prophylactic Drug Treatment of Pediatric Migraine: What Is New in 2017 and Where Does It Leave Us? Curr Pain Headache Rep [Internet]. 2017 Aug 4 [cited 2019 Jun 3];21(8):38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28779443.
  33. 33.
    Deer TR, Mekhail N, Petersen E, Krames E, Staats P, Pope J, et al. The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation. 2014;17:551–70.CrossRefGoogle Scholar
  34. 34.
    Ehrhardt KP, Mothersele SM, Brunk AJ, Green JB, Jones MR, Billeaud CB, et al. Spinal cord stimulation, MILD procedure, and regenerative medicine, novel interventional nonopioid therapies in chronic pain. Curr Pain Headache Rep Current Pain and Headache Reports. 2018;22:1–7.CrossRefGoogle Scholar
  35. 35.
    Walling I, Panse D, Gee L, Maietta T, Kaszuba B, Kumar V, et al. The use of focused ultrasound for the treatment of cutaneous allodynia associated with chronic migraine. Brain Res Elsevier BV. 2018;1699:135–41.CrossRefGoogle Scholar
  36. 36.
    Benemei S, Cortese F, Labastida-Ramírez A, Marchese F, Pellesi L, Romoli M, et al. Triptans and CGRP blockade – impact on the cranial vasculature. J. Headache Pain. 2017;18:103.CrossRefGoogle Scholar
  37. 37.
    Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltrán E, et al. Blocking CGRP in migraine patients – a review of pros and cons. J Headache Pain. 2017;18:96.CrossRefGoogle Scholar
  38. 38.
    Al-Quliti KW, Assaedi ES. New advances in prevention of migraine. Review of current practice and recent advances. Neurosciences (Riyadh) [Internet]. Medical Services Division, Ministry of Defence; 2016 [cited 2019 may 14];21:207–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27356650.
  39. 39.
    Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults report of the quality standards subcommittee of the American academy of neurology and the american headache society. Neurology. 2012;78:1337–45.CrossRefGoogle Scholar
  40. 40.
    Gelfand AA, Goadsby PJ. The role of melatonin in the treatment of primary headache disorders. Headache. 2016;56:1257–66.CrossRefGoogle Scholar
  41. 41.
    Diener HC, Charles A, Goadsby PJ, Holle D. New therapeutic approaches for the prevention and treatment of migraine. Lancet Neurol. 2015;14:1010–22.CrossRefGoogle Scholar
  42. 42.
    Cao Y, Zheng OJ. Tonabersat for migraine prophylaxis: a systematic review. Pain Physician [Internet]. [cited 2019 Jun 3];17(1):1–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24452641.
  43. 43.
    Kelley NE, Tepper DE. Rescue Therapy for Acute Migraine, Part 2: Neuroleptics, Antihistamines, and Others. Headache J Head Face Pain [Internet]. 2012 Feb [cited 2019 Jun 3];52(2):292–306. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22309235.
  44. 44.
    Eken C. Critical reappraisal of intravenous metoclopramide in migraine attack: a systematic review and meta-analysis. Am J Emerg Med. 2015;33:331–7.CrossRefGoogle Scholar
  45. 45.
    Najjar M, Hall T, Estupinan B. Metoclopramide for Acute Migraine Treatment in the Emergency Department: An Effective Alternative to Opioids. Cureus [Internet]. 2017 Apr 20 [cited 2019 Jun 3];9(4):e1181. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28533997.
  46. 46.
    Mwamburi M, Tenaglia AT, Leibler EJ, Staats PS. Review of evidence on noninvasive vagus nerve stimulation for treatment of migraine: efficacy, safety, and implications. Am J Manag Care. 2018 Dec;24(24 Suppl):S507–16.PubMedGoogle Scholar
  47. 47.
    Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018 Jul 24;91(4):e364–73.CrossRefGoogle Scholar
  48. 48.
    Grazzi L, Egeo G, Liebler E, Padovan AM, Barbanti P. Non-invasive vagus nerve stimulation as symptomatic treatment of migraine in young patients: a preliminary safety study. Neurol Sci. 2017 May;38(Suppl 1):197–9.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Alan David Kaye
    • 1
  • Mark W. Motejunas
    • 1
  • Elyse M. Cornett
    • 2
    Email author
  • Ken P. Ehrhardt
    • 1
  • Matthew B. Novitch
    • 3
  • Joshua Class
    • 4
  • Harish Siddaiah
    • 2
  • Brendon M. Hart
    • 2
  • Richard D. Urman
    • 4
  1. 1.Department of AnesthesiologyLSU Health Sciences CenterNew OrleansUSA
  2. 2.Department of AnesthesiologyLSU Health ShreveportShreveportUSA
  3. 3.University of Washington AnesthesiologySeattleUSA
  4. 4.Department of Anesthesiology, Perioperative and Pain MedicineHarvard Medical School, Brigham and Women’s HospitalBostonUSA

Personalised recommendations